Lilly's New Podcast Series

The Elixir Factor, Lilly’s new podcast hosted by Joe Kim, senior advisor of patient experience and design, explores the factors that inspire bold advances in science, innovation and the resilience required to change history. Tune in to hear how the Lilly research and development (R&D) team collaborates with partners in advocacy, technology, academia and policy to seek cures or solutions for some of the most difficult diseases. There is always a way to get better at what you are doing – simply say "yes" to the next step. Say yes and subscribe today via your preferred podcasting platform:

Elixir Factor Podcast Elixir Factor Podcast Elixir Factor Podcast Elixir Factor Podcast

Our First Season

Episode 1: Precision Medicine

Most of us know a person impacted by cancer. Yet while cancer research has been going on for centuries, we still don’t have a cure. Two major advances, targeted therapy and immunotherapy, have led oncologists to the practice of precision medicine. On this episode, Joe talks to T.J. Sharpe, a cancer survivor and patient advocate. Hear what factors led him to research an alternative treatment plan for stage IV melanoma versus a standard treatment plan, which offered him only months to live. Joe also talks with two passionate Lilly scientists, Dr. Kim Blackwell and Dr. Levi Garraway, who lead the way in oncology research and development, specifically in the area of precision medicine.


Episode 2: Debunking the Myths of Clinical Trials

Why is research important and why do people participate? Finding new and improved medicines is only possible with the help of brave people who participate in clinical trials. On this episode, Joe talks with Lilly Stairs, head of growth and partnership at Savvy Cooperative. Hear what factors caused her transformation from ordinary citizen to passionate patient advocate. Joe and Lilly also debunk the myths associated with clinical trials with Lilly’s own Leigh Anne Naas, a patient experience and design innovation community leader.


Episode 3: Inside the Turning Point

Alzheimer’s disease is one of the biggest unmet medical needs of our time. Lilly has been committed to Alzheimer’s research for more than 30 years, and continues to remain determined to find solutions for this horrible disease. In 2015, Lilly provided a grant to Academy Award–nominated filmmaker and health care advocate James Keach to make the documentary Turning Point, which granted him access into “the cave” as the Lilly team learned the fate of the Alzheimer’s Expedition 3 study. On this episode, Joe talks with James and Ron DeMattos, Lilly’s chief scientific officer for neurobiologics. Hear what factors inspired the making of Turning Point and the story of the Lilly scientists on the front lines of Alzheimer’s research, capturing both the disappointment and resilience of those working to disrupt the disease.


Episode 4: Courage & Caregiving

Caregiving can be one of the most stressful, emotional and physically exhausting jobs there is. Nearly half of all caregivers who provide help to other adults do so for someone living with Alzheimer’s or dementia. The role of the caregiver also goes far beyond basic day-to-day care. They are also the "voice of the patient" and play a very important role in future solutions. On this episode, Joe talks to a full-time Lilly employee and full-time caregiver, Beth Stafford. Hear what factors motivated her to seek the help of Denise Saxman, care consultant at the Alzheimer’s Association, during her caregiving journey. Joe also talks to Denise about ways to help caregivers and the importance of recognizing them as part of the equation in health care, and in drug discovery and development.


Episode 5: The Complexity of Pain

Pain is a uniquely complex problem. As many of us know, pain does not discriminate. It’s personal. It’s subjective, and it affects everyone differently. Pain is also an incredibly challenging area to research because of how subjective it can be. Investigational programs for innovative pain treatments have one of the highest clinical-trial failure rates of any major disease state. Now, new advances in digital health may offer scientists the ability to gain more insight on the course of pain. On this episode, Joe talks to Seth Ginsberg, a health policy advocate and entrepreneur. Hear what factors led him to co-found CreakyJoints, the first online patient community for people suffering from arthritis. Joe also talks to one our of own Lilly scientists, Dr. Mark Mintun, about why pain has proven to be such a challenging area to research.


Learn more about Lilly's R&D efforts here.